Role of CCL20/CCR6 and the ERK signaling pathway in lung adenocarcinoma

Zhang,Xiao‑Peng; Hu,Zhi‑Juan; Meng,Ai‑Hong; Duan,Guo‑Chen; Zhao,Qing‑Tao; Yang,Jing

doi:10.3892/ol.2017.7253

Role of CCL20/CCR6 and the ERK signaling pathway in lung adenocarcinoma

Authors:
- Xiao‑Peng Zhang
- Zhi‑Juan Hu
- Ai‑Hong Meng
- Guo‑Chen Duan
- Qing‑Tao Zhao
- Jing Yang
View Affiliations

Affiliations: Department of Thoracic Surgery, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China, Department of Nephrology, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China, Respiratory Division, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050050, P.R. China, Respiratory Division, Hebei General Hospital, Shijiazhuang, Hebei 050051, P.R. China
Published online on: October 23, 2017 https://doi.org/10.3892/ol.2017.7253
Pages: 8183-8189

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous studies have revealed that carcinoma‑associated fibroblasts communicate microenvironment-derived signals through chemokine/chemokine receptor interaction, resulting in carcinogenesis. C‑C motif chemokine ligand 20 (CCL20)/C‑C motif chemokine receptor 6 (CCR6) interactions are involved in the pathogenesis of colonic malignancies. The present study aimed to characterize the roles of CCL20/CCR6 and the extracellular signal‑regulated kinase (ERK) signaling pathway in lung adenocarcinoma growth. Lung adenocarcinoma samples obtained at surgery were assessed for the expression, tissue localization and production of CCL20/CCR6. In addition, colony formation, ERK signaling and chemokine production were measured to assess the responsiveness of the A549 cell line to CCL20 stimulation. CCL20 and CCR6 were found to be highly expressed in the majority of samples in the recurrence group (76 and 66%, respectively). The staining indexes of CCL20 and CCR6 in the recurrence group were 149.3 and 134.4, respectively, which were significantly higher than those in the non‑recurrence group (57.2 and 58.0, respectively); the protein and mRNA expression levels determined by western blot and reverse transcription‑quantitative polymerase chain reaction were also found to be high in the recurrence group For A549 cells, the colony‑forming capacity was increased by CCL20 stimulation, and this effect was dependent in part on ERK phosphorylation. Collectively, the findings suggest that CCR6 and CCL20 may serve a role in lung adenocarcinoma, leading to proliferation and migration via autocrine or paracrine mechanisms. The disruption of CCL20/CCR6 interactions may be a promising strategy for the treatment of cancer.

View Figures

View References

1	Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005. View Article : Google Scholar : PubMed/NCBI
2	Spiro SG and Silvestri GA: One hundred years of lung cancer. Am J Respir Crit Care Med. 172:523–529. 2005. View Article : Google Scholar : PubMed/NCBI
3	Radzikowska E, Głaz P and Roszkowski K: Lung cancer in women: Age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol. 13:1087–1093. 2002. View Article : Google Scholar : PubMed/NCBI
4	Murphy PM, Baggiolini M, Charo IF, Hébert CA, Horuk R, Matsushima K, Miller LH, Oppenheim JJ and Power CA: International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev. 52:145–176. 2000.PubMed/NCBI
5	Mantovani A, Allavena P, Sozzani S, Vecchi A, Locati M and Sica A: Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors. Semin Cancer Biol. 14:155–160. 2004. View Article : Google Scholar : PubMed/NCBI
6	Mantovani A: Chemokines in neoplastic progression. Semin Cancer Biol. 14:147–148. 2004. View Article : Google Scholar : PubMed/NCBI
7	Beider K, Abraham M, Begin M, Wald H, Weiss ID, Wald O, Pikarsky E, Abramovitch R, Zeira E, Galun E, et al: Interaction between CXCR4 and CCL20 pathways regulates tumor growth. PLoS One. 4:e51252009. View Article : Google Scholar : PubMed/NCBI
8	Schutyser E, Struyf S and Van Damme J: The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 14:409–426. 2003. View Article : Google Scholar : PubMed/NCBI
9	Bracke KR, Demedts IK, Joos GF and Brusselle GG: CC-chemokine receptors in chronic obstructive pulmonary disease. Inflamm Allergy Drug Targets. 6:75–79. 2007. View Article : Google Scholar : PubMed/NCBI
10	Demedts IK, Bracke KR, Van Pottelberge G, Testelmans D, Verleden GM, Vermassen FE, Joos GF and Brusselle GG: Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 175:998–1005. 2007. View Article : Google Scholar : PubMed/NCBI
11	Ghadjar P, Rubie C, Aebersold DM and Keilholz U: The chemokine CCL20 and its receptor CCR6 in human malignancy with focus on colorectal cancer. Int J Cancer. 125:741–745. 2009. View Article : Google Scholar : PubMed/NCBI
12	Roberts PJ and Der CJ: Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene. 26:3291–3310. 2007. View Article : Google Scholar : PubMed/NCBI
13	Huang YC, Hsiao YC, Chen YJ, Wei YY, Lai TH and Tang CH: Stromal cell-derived factor-1 enhances motility and integrin up-regulation through CXCR4, ERK and NF-kappaB-dependent pathway in human lung cancer cells. Biochem Pharmacol. 74:1702–1712. 2007. View Article : Google Scholar : PubMed/NCBI
14	Ganju RK, Brubaker SA, Meyer J, Dutt P, Yang Y, Qin S, Newman W and Groopman JE: The alpha-chemokine, stromal cell-derived factor-1alpha, binds to the transmembrane G-protein-coupled CXCR-4 receptor and activates multiple signal transduction pathways. J Biol Chem. 273:23169–23175. 1998. View Article : Google Scholar : PubMed/NCBI
15	Barbero S, Bonavia R, Bajetto A, Porcile C, Pirani P, Ravetti JL, Zona GL, Spaziante R, Florio T and Schettini G: Stromal cell-derived factor 1alpha stimulates human glioblastoma cell growth through the activation of both extracellular signal-regulated kinases 1/2 and Akt. Cancer Res. 63:1969–1974. 2003.PubMed/NCBI
16	Brand S, Olszak T, Beigel F, Diebold J, Otte JM, Eichhorst ST, Göke B and Dambacher J: Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. J Cell Biochem. 97:709–723. 2006. View Article : Google Scholar : PubMed/NCBI
17	Lee W, Jiang Z, Liu J, Haverty PM, Guan Y, Stinson J, Yue P, Zhang Y, Pant KP, Bhatt D, et al: The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature. 465:473–477. 2010. View Article : Google Scholar : PubMed/NCBI
18	Mountain CF: Revisions in the International System for staging lung cancer. Chest. 111:1710–1717. 1997. View Article : Google Scholar : PubMed/NCBI
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Dleta C(T) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
20	Wang JM, Deng X, Gong W and Su S: Chemokines and their role in tumor growth and metastasis. J Immunol Methods. 220:1–17. 1998. View Article : Google Scholar : PubMed/NCBI
21	Balkwill F and Mantovani A: Inflammation and cancer: Back to Virchow? Lancet. 357:539–545. 2001. View Article : Google Scholar : PubMed/NCBI
22	Vicari AP and Caux C: Chemokines in cancer. Cytokine Growth Factor Rev. 13:143–154. 2002. View Article : Google Scholar : PubMed/NCBI
23	Kleeff J, Kusama T, Rossi DL, Ishiwata T, Maruyama H, Friess H, Büchler MW, Zlotnik A and Korc M: Detection and localization of MIP-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer. 81:650–657. 1999. View Article : Google Scholar : PubMed/NCBI
24	Bell D, Chomarat P, Broyles D, Netto G, Harb GM, Lebecque S, Valladeau J, Davoust J, Palucka KA and Banchereau J: In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med. 190:1417–1426. 1999. View Article : Google Scholar : PubMed/NCBI
25	Shimizu Y, Murata H, Kashii Y, Hirano K, Kunitani H, Higuchi K and Watanabe A: CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3alpha might be involved in the amplification of local necroinflammatory response in the liver. Hepatology. 34:311–319. 2001. View Article : Google Scholar : PubMed/NCBI
26	Kimsey TF, Campbell AS, Albo D, Wilson M and Wang TN: Co-localization of macrophage inflammatory protein-3alpha (Mip-3alpha) and its receptor, CCR6, promotes pancreatic cancer cell invasion. Cancer J. 10:374–380. 2004. View Article : Google Scholar : PubMed/NCBI
27	Ghadjar P, Coupland SE, Na IK, Noutsias M, Letsch A, Stroux A, Bauer S, Buhr HJ, Thiel E, Scheibenbogen C and Keilholz U: Chemokine receptor CCR6 expression level and liver metastasis in colorectal cancer. J Clin Oncol. 24:1910–1916. 2006. View Article : Google Scholar : PubMed/NCBI